Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers

Gangadharan B., Kumar A., Cobbold J., Dwek RA., Thursz M., Zitzmann N.

The invention relates to methods of diagnosing, prognosing, or monitoring or staging the progression of non-alcoholic fatty liver disease (NAFLD) using biomarkers. The invention also relates to a method of scoring to determine the severity of NAFLD, and a method of treating NAFLD.

Type

Patent

Publication Date

2018-03-01T00:00:00+00:00

Permalink More information Close